Disclosures for "Compound 2a Protects Against Dopaminergic Neuronal Degeneration in a Mouse Model of Parkinson’s Disease "
-
Dr. Persico has nothing to disclose.
-
Dr. Fang has nothing to disclose.
-
Simona Eleuteri has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation.